반응식
[O:1]1[CH:5]=[N:4][N:3]=[C:2]1[NH2:6].[CH:7]1[C:20]2[CH:19]([C:21](Cl)=[O:22])[C:18]3[C:13](=[CH:14][CH:15]=[CH:16][CH:17]=3)[O:12][C:11]=2[CH:10]=[CH:9][CH:8]=1>>[O:1]1[CH:5]=[N:4][N:3]=[C:2]1[NH:6][C:21]([CH:19]1[C:20]2[CH:7]=[CH:8][CH:9]=[CH:10][C:11]=2[O:12][C:13]2[C:18]1=[CH:17][CH:16]=[CH:15][CH:14]=2)=[O:22]참가 물질
3
실험 절차
The title compound, white solid, m.p. 239-240° C. and MS: m/e=293 (M+) was prepared in accordance with the general method of example 44a from [1,3,4]oxadiazol-2-ylamine and 9-xanthene-carboxylic acid chloride. The [1,3,4]oxadiazol-2-ylamine, white solid, MS: m/e=85 (M+) used in the above reaction was prepared in accordance with the general method of example 44b from formic acid hydrazide and cyanogen bromide.
출처 및 근거
- ORD 기록
- ord-2c3625b284ee4fb49276715fc2d426fe
- 출처 데이터셋
- uspto-grants-2002_10
- 특허 번호
- US06462198B1
연결된 노트
불러오는 중…